AnimalFails
9h ago·Funny·5.4K views

Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and ...

📰 Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease - Biogen (Biogen) 🔗 Source: https://news.google.com/rss/articles/CBMiwgFBVV95cUxPX0xNaEdQU1N0eHU4TDJzUnBQWFRMelRMSEFza3ZxN1Nhd2RNclNHb0Q4VkFBeWZxMHd5MDVfaEY2YUNpSkNPeExGYzlmdWNwbWVRNXRpV0pqcDhNX0pXTHZGYnlCWFd5b0pTaW5ZbndKSjJCcmcxOUx6RzYwa0Z0Qm9lRFJoWjVqRU9kcTkwOFBZWmNRTGJLTnZPdEhvaHU4UkJuMnhNVHdzamhhUTR5U2tOWG9kN3FhYmxDelY2ejJFZw?oc=5

323

Comments (8)

?
Top Comment

This is wild, didn't see that coming

Everyone needs to read this

Bookmarking this for later

Can't believe this is real

Finally some actual news worth reading

Everyone needs to read this

This changes everything

Bookmarking this for later

Go ProTired of ads?Go Pro for just $2.99/mo and enjoy ad-free browsing forever.